id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
work_rlj2y2v7rbbpjitmtfjilleqki	A. H. Skolnick	Older Adults in Clinical Research and Drug Development: Closing the Geriatric Gap	2015.0	3	.pdf	application/pdf	2264	237	48	As cardiovascular specialists, we are caring for a rapidly growing number of older adults despite limited data to and reporting trends to assess inclusion of older adults in clinical trials.6 However, as a medical community, we have yet to FDA published the ICH-E7 Studies in Support of Special Populations: Geriatrics Guidance for Industry, which presented of including older adults in research, encouraged early discussions with FDA, and outlined similar suggestions to those point for clinical trial populations, age ≥75 years better reflects Older Adults in Clinical Research and Drug Development Older Adults in Clinical Research and Drug Development older adults in National Institutes of Health clinical research. Second, Congress could create an Office of Geriatric Health and Aging within the FDA to of evidence for risk-to-benefit of a drug in older adults. The persistent exclusion of older patients from ongoing clinical trials regarding heart failure.	./cache/work_rlj2y2v7rbbpjitmtfjilleqki.pdf	./txt/work_rlj2y2v7rbbpjitmtfjilleqki.txt